Product
ALS20
1 clinical trial
1 indication
Indication
Beta ThalassemiaClinical trial
Phase 1/2 Study Evaluating the Safety and Efficacy of Gene Therapy Employing Lentiviral Vector ALS20-transduced Hematopoietic Progenitor Cells in Subjects With Transfusion-dependent-thalassemiaStatus: Not yet recruiting, Estimated PCD: 2027-12-31